184 related articles for article (PubMed ID: 22365772)
21. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.
Björgvinsdóttir H; Ding C; Pech N; Gifford MA; Li LL; Dinauer MC
Blood; 1997 Jan; 89(1):41-8. PubMed ID: 8978275
[TBL] [Abstract][Full Text] [Related]
22. Toxicity of repeated intravenous injection of gene therapeutics for X-CGD in mice.
Lee YM; Choi WH; Kim YB; Ha CS; Song CW; Lee M; Joo CW; Hong Y; Ho SH; Kim S; Kim JM; Koh WS
Hum Exp Toxicol; 2008 May; 27(5):401-7. PubMed ID: 18715886
[TBL] [Abstract][Full Text] [Related]
23. A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression.
Sokolic RA; Sekhsaria S; Sugimoto Y; Whiting-Theobald N; Linton GF; Li F; Gottesman MM; Malech HL
Blood; 1996 Jan; 87(1):42-50. PubMed ID: 8547675
[TBL] [Abstract][Full Text] [Related]
24. High-level reconstitution of respiratory burst activity in a human X-linked chronic granulomatous disease (X-CGD) cell line and correction of murine X-CGD bone marrow cells by retroviral-mediated gene transfer of human gp91phox.
Ding C; Kume A; Björgvinsdóttir H; Hawley RG; Pech N; Dinauer MC
Blood; 1996 Sep; 88(5):1834-40. PubMed ID: 8781441
[TBL] [Abstract][Full Text] [Related]
25. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
[TBL] [Abstract][Full Text] [Related]
26. Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
Rappa G; Anzanello F; Alexeyev M; Fodstad O; Lorico A
Eur J Haematol; 2007 May; 78(5):440-8. PubMed ID: 17331133
[TBL] [Abstract][Full Text] [Related]
27. Enhancer-deleted retroviral vectors restore high levels of superoxide generation in a mouse model of CGD.
Schwickerath O; Brouns G; Thrasher A; Kinnon C; Roes J; Casimir C
J Gene Med; 2004 Jun; 6(6):603-15. PubMed ID: 15170731
[TBL] [Abstract][Full Text] [Related]
28. Gene correction of induced pluripotent stem cells derived from a murine model of X-linked chronic granulomatous disorder.
Mukherjee S; Thrasher AJ
Methods Mol Biol; 2014; 1114():427-40. PubMed ID: 24557920
[TBL] [Abstract][Full Text] [Related]
29. Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft.
Naumann N; De Ravin SS; Choi U; Moayeri M; Whiting-Theobald N; Linton GF; Ikeda Y; Malech HL
Gene Ther; 2007 Nov; 14(21):1513-24. PubMed ID: 17728796
[TBL] [Abstract][Full Text] [Related]
30. Functional Restoration of gp91phox-Oxidase Activity by BAC Transgenesis and Gene Targeting in X-linked Chronic Granulomatous Disease iPSCs.
Laugsch M; Rostovskaya M; Velychko S; Richter C; Zimmer A; Klink B; Schröck E; Haase M; Neumann K; Thieme S; Roesler J; Brenner S; Anastassiadis K
Mol Ther; 2016 Apr; 24(4):812-22. PubMed ID: 26316390
[TBL] [Abstract][Full Text] [Related]
31. Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.
Zentilin L; Tafuro S; Grassi G; Garcia R; Ventura A; Baralle F; Falaschi A; Giacca M
Exp Cell Res; 1996 Jun; 225(2):257-67. PubMed ID: 8660913
[TBL] [Abstract][Full Text] [Related]
32. Genetic correction of X-linked chronic granulomatous disease with novel foamy virus vectors.
Chatziandreou I; Siapati EK; Vassilopoulos G
Exp Hematol; 2011 Jun; 39(6):643-52. PubMed ID: 21426924
[TBL] [Abstract][Full Text] [Related]
33. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
[TBL] [Abstract][Full Text] [Related]
34. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model.
Hanania EG; Deisseroth AB
Cancer Gene Ther; 1994 Mar; 1(1):21-5. PubMed ID: 7621234
[TBL] [Abstract][Full Text] [Related]
35. Successful hematopoietic stem cell transplantation in 2 children with X-linked chronic granulomatous disease from their unaffected HLA-identical siblings selected using preimplantation genetic diagnosis combined with HLA typing.
Goussetis E; Konialis CP; Peristeri I; Kitra V; Dimopoulou M; Petropoulou T; Vessalas G; Papassavas A; Tzanoudaki M; Kokkali G; Petrakou E; Spiropoulos A; Pangalos CG; Pantos K; Graphakos S
Biol Blood Marrow Transplant; 2010 Mar; 16(3):344-9. PubMed ID: 19835970
[TBL] [Abstract][Full Text] [Related]
36. Signed outside: a surface marker system for transgenic cytoplasmic proteins.
Wohlgensinger V; Seger R; Ryan MD; Reichenbach J; Siler U
Gene Ther; 2010 Oct; 17(10):1193-9. PubMed ID: 20445581
[TBL] [Abstract][Full Text] [Related]
37. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
Horwitz ME; Barrett AJ; Brown MR; Carter CS; Childs R; Gallin JI; Holland SM; Linton GF; Miller JA; Leitman SF; Read EJ; Malech HL
N Engl J Med; 2001 Mar; 344(12):881-8. PubMed ID: 11259721
[TBL] [Abstract][Full Text] [Related]
38. A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications.
Goebel WS; Pech NK; Meyers JL; Srour EF; Yoder MC; Dinauer MC
Exp Hematol; 2004 Dec; 32(12):1255-64. PubMed ID: 15588950
[TBL] [Abstract][Full Text] [Related]
39. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease.
Mardiney M; Jackson SH; Spratt SK; Li F; Holland SM; Malech HL
Blood; 1997 Apr; 89(7):2268-75. PubMed ID: 9116268
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Bielorai B; Toren A; Wolach B; Mandel M; Golan H; Neumann Y; Kaplinisky C; Weintraub M; Keller N; Amariglio N; Paswell J; Rechavi G
Bone Marrow Transplant; 2000 Nov; 26(9):1025-8. PubMed ID: 11100285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
